Globus Medical (GMED) Free Cash Flow (2011 - 2026)

Globus Medical (GMED) has reported Free Cash Flow for 16 consecutive years, with $176.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow rose 464.08% year-over-year to $176.6 million; the trailing twelve-month figure through Jun 2026 stood at $755.6 million (up 43.26% YoY), and the FY2025 full-year result was $588.8 million, up 45.3% from the prior year.
• Free Cash Flow grew to $176.6 million in Q2 2026 per GMED's latest filing, from $162.7 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $213.9 million in Q3 2025 and bottomed at $13.1 million in Q2 2022.
• Historically, Free Cash Flow has averaged $89.1 million across 5 years, with a median of $41.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 74.16% in 2022, then surged 492.79% in 2025.
• Over 5 years, Free Cash Flow stood at $45.6 million in 2022, then jumped by 79.23% to $81.8 million in 2023, then jumped by 136.24% to $193.2 million in 2024, then rose by 4.74% to $202.4 million in 2025, then retreated by 12.76% to $176.6 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $176.6 million, $162.7 million, and $202.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.